Deborah Norville Launches National Hope Relay in Celebration of People Leading Active Lives Despite their Rheumatoid Arthritis Read more about Deborah Norville Launches National Hope Relay in Celebration of People Leading Active Lives Despite their Rheumatoid Arthritis
Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer Read more about Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer
Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers Read more about Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers
Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) Read more about Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO) Read more about Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO)
Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 Read more about Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29
Amgen Announces Webcast of 2009 Second Quarter Financial Results Read more about Amgen Announces Webcast of 2009 Second Quarter Financial Results
Amgen Scholars Discover Their Potential During Summer Science Research Program and National Symposium Read more about Amgen Scholars Discover Their Potential During Summer Science Research Program and National Symposium
Amgen Announces KRAS Safety Update to U.S. Prescribing Information for Vectibix(R) (Panitumumab) Read more about Amgen Announces KRAS Safety Update to U.S. Prescribing Information for Vectibix(R) (Panitumumab)
Amgen Appoints Rebecca M. Henderson to the Company's Board of Directors Read more about Amgen Appoints Rebecca M. Henderson to the Company's Board of Directors
